Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA
A Genotype-phenotype Correlation of SLC26A4 Mutations in Cochlear-implanted Patients With Enlarged Vestibular Aqueduct
1 other identifier
observational
60
0 countries
N/A
Brief Summary
To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with enlarged vestibular aqueduct.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 10, 2021
CompletedFirst Posted
Study publicly available on registry
June 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedJune 22, 2021
April 1, 2021
11 years
June 10, 2021
June 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cochlear implant age
Age of cochlear implantation.
Immediately after cochlear implantation
Duration of hearing loss
Time between found of hearing loss and cochlear implantation.
Immediately after cochlear implantation
Secondary Outcomes (2)
Type of initial hearing loss
On the 1 day of recruitment.
Type of hearing loss progression
Immediately after cochlear implantation
Interventions
Cochlear implantation
Eligibility Criteria
Subjects with sensorineural hearing loss and enlarged vestibular aqueduct.
You may qualify if:
- Bilateral severe-to-profound sensorineural hearing loss who received cochlear implantation.
- Bilateral or unilateral enlarged vestibular aqueduct (EVA) with or without Mondini malformation (IP-II) on temporal bone computed tomography (CT) and/or magnetic resonance imaging (MRI).
You may not qualify if:
- Hearing loss that is associated with symptoms which meet the criteria of already known syndromes.
- With other type of inner ear malformation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiao Liu, MD
Department of Otorhinolaryngology, 2nd Affiliated Hospital, School of Medicine, Zhejiang University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2021
First Posted
June 22, 2021
Study Start
May 1, 2010
Primary Completion
May 1, 2021
Study Completion
July 1, 2021
Last Updated
June 22, 2021
Record last verified: 2021-04